NO995338L - Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer - Google Patents
Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorerInfo
- Publication number
- NO995338L NO995338L NO995338A NO995338A NO995338L NO 995338 L NO995338 L NO 995338L NO 995338 A NO995338 A NO 995338A NO 995338 A NO995338 A NO 995338A NO 995338 L NO995338 L NO 995338L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- optionally substituted
- group
- hydrogen
- substituent
- Prior art date
Links
- 102000004073 Dopamine D3 Receptors Human genes 0.000 title 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 title 1
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000005392 carboxamide group Chemical group NC(=O)* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Forbindelser med formel (l): Formel (I) hvor R1 representerer en substituent valgt fra hydrogen eller en substituent som definert i kravene, R2 representerer et hydrogenatom eller en C"|-4alkylgruppe; q er 1 eller 2; A representerer en gruppe med formelen (a), (b) eller (c): ¿Ar -----Ar1¿Y¿Ar (a) (b) (c) hvor Ar representerer en eventuelt substituert fenylring eller en eventuelt substituert 5- eller 6- leddet aromatisk heterocyklisk ring; eller en eventuelt substituert bicyklisk ringsystem; Ar"! og Ar^ hver uavhengig representerer en eventuelt substituert fenylring eller en eventuelt substituert 5- eller 6- leddet aromatisk heterocyklisk ring; og Y representerer en binding, -NHCO-, -CONH-, -CH2-eller-(CH2)mYl(CH2)n-. hvor Y1 representerer O, S, SC>2 eller CO og m og n hver representerer null eller 1 slik at summen of m+n er null eller 1; forutsatt at når A representerer en gruppe med formel (a), er en hvilken som helst substituent til stede i Ar orto til karboksamidgruppen, nødvendigvis hydrogen eller metoksy; og salter derav.. Forbindelser med formel (l) og deres salter har affinitet for dopamin-reseptorer, spesielt Ds-reseptoren og har således potensiale ved behandling av tilstander hvor modulering av D3-reseptoren er fordelaktig, f.eks. som antipsykotiske midler.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9708976.7A GB9708976D0 (en) | 1997-05-03 | 1997-05-03 | Compounds |
GBGB9723294.6A GB9723294D0 (en) | 1997-11-04 | 1997-11-04 | Compounds |
PCT/EP1998/002583 WO1998050364A1 (en) | 1997-05-03 | 1998-04-27 | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995338D0 NO995338D0 (no) | 1999-11-02 |
NO995338L true NO995338L (no) | 1999-11-02 |
Family
ID=26311476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995338A NO995338L (no) | 1997-05-03 | 1999-11-02 | Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer |
Country Status (17)
Country | Link |
---|---|
US (1) | US6465485B1 (no) |
EP (1) | EP0983244A1 (no) |
JP (1) | JP2002501506A (no) |
CN (1) | CN1261350A (no) |
AR (1) | AR013078A1 (no) |
AU (1) | AU725491B2 (no) |
BR (1) | BR9809591A (no) |
CA (1) | CA2288899A1 (no) |
HU (1) | HUP0003608A3 (no) |
IL (1) | IL132631A0 (no) |
MA (1) | MA26490A1 (no) |
NO (1) | NO995338L (no) |
PE (1) | PE68799A1 (no) |
PL (1) | PL336628A1 (no) |
TR (1) | TR199902724T2 (no) |
UY (1) | UY24986A1 (no) |
WO (1) | WO1998050364A1 (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
CN1158264C (zh) * | 1997-11-21 | 2004-07-21 | Nps药物有限公司 | 用于治疗中枢神经系统疾病的代谢性谷氨酸受体拮抗剂 |
US6429207B1 (en) * | 1997-11-21 | 2002-08-06 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
GB9810876D0 (en) * | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
GB9812522D0 (en) * | 1998-06-10 | 1998-08-05 | Smithkline Beecham Plc | Compounds |
US6855717B2 (en) * | 1998-06-10 | 2005-02-15 | Smithkline Beecham, Plc | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
JP2002527433A (ja) | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ドーパミンd3受容体のモジュレーター(抗精神病薬)として有用なテトラヒドロベンズアゼピン誘導体 |
GB9821978D0 (en) * | 1998-10-08 | 1998-12-02 | Smithkline Beecham Plc | Compounds |
GB9821977D0 (en) | 1998-10-08 | 1998-12-02 | Smithkline Beecham Plc | Compounds |
AR022230A1 (es) | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion |
HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
AU2003218660A1 (en) * | 2002-02-13 | 2003-09-04 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
GB0330043D0 (en) | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them |
GB0330042D0 (en) | 2003-12-24 | 2004-01-28 | Pharmacia Italia Spa | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them |
GB0403038D0 (en) * | 2004-02-11 | 2004-03-17 | Novartis Ag | Organic compounds |
JP2009511530A (ja) * | 2005-10-13 | 2009-03-19 | モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー | 抗菌活性を有する5−キノリン誘導体 |
EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
US9227944B2 (en) | 2008-10-10 | 2016-01-05 | Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China | Dopamine D3 receptor ligands and preparation and medical uses of the same |
EP2354136B1 (en) | 2008-10-10 | 2016-02-24 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | Novel dopamine d3 receptor ligands and preparation and medical uses of the same |
AU2012351748B2 (en) * | 2011-12-12 | 2016-04-14 | Dr. Reddy's Laboratories Ltd. | Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors |
WO2018021447A1 (ja) | 2016-07-28 | 2018-02-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物 |
HUE049979T2 (hu) | 2017-03-20 | 2020-11-30 | Forma Therapeutics Inc | Pirrolopirrol készítmények piruvát-kináz (PKR) aktivátorokként |
CN111801330B (zh) * | 2018-01-26 | 2024-04-05 | 盐野义制药株式会社 | 具有多巴胺d3受体拮抗作用的稠环化合物 |
BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
CN113226356A (zh) | 2018-09-19 | 2021-08-06 | 福马治疗股份有限公司 | 活化丙酮酸激酶r |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4220778A (en) * | 1978-10-30 | 1980-09-02 | G. D. Searle & Co. | 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof |
US5047406A (en) * | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
FR2706895A1 (en) * | 1993-06-22 | 1994-12-30 | Synthelabo | Tetrahydroisoquinoline derivatives, their preparation and their application in therapeutics |
GB9402807D0 (en) | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
US5891877A (en) | 1995-02-14 | 1999-04-06 | Xenova Limited | Pharmaceutical compounds |
US5977110A (en) | 1995-09-22 | 1999-11-02 | Warner-Lambert Company | Substituted cyclohexylamines as central nervous systems agents |
NZ332477A (en) * | 1996-05-11 | 2000-07-28 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
CA2263284A1 (en) * | 1996-08-14 | 1998-02-19 | Smithkline Beecham P.L.C. | Tetrahydroisoquinoline derivatives and their pharmaceutical use |
GB9708694D0 (en) | 1997-04-30 | 1997-06-18 | Smithkline Beecham Plc | Compounds |
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
-
1998
- 1998-04-27 BR BR9809591-9A patent/BR9809591A/pt not_active IP Right Cessation
- 1998-04-27 HU HU0003608A patent/HUP0003608A3/hu unknown
- 1998-04-27 WO PCT/EP1998/002583 patent/WO1998050364A1/en not_active Application Discontinuation
- 1998-04-27 CA CA002288899A patent/CA2288899A1/en not_active Abandoned
- 1998-04-27 IL IL13263198A patent/IL132631A0/xx unknown
- 1998-04-27 EP EP98924262A patent/EP0983244A1/en not_active Withdrawn
- 1998-04-27 AU AU76518/98A patent/AU725491B2/en not_active Ceased
- 1998-04-27 PL PL98336628A patent/PL336628A1/xx unknown
- 1998-04-27 CN CN98806643A patent/CN1261350A/zh active Pending
- 1998-04-27 JP JP54771298A patent/JP2002501506A/ja active Pending
- 1998-04-27 TR TR1999/02724T patent/TR199902724T2/xx unknown
- 1998-04-29 PE PE1998000326A patent/PE68799A1/es not_active Application Discontinuation
- 1998-04-30 AR ARP980102028A patent/AR013078A1/es not_active Application Discontinuation
- 1998-04-30 UY UY24986A patent/UY24986A1/es unknown
- 1998-04-30 MA MA25053A patent/MA26490A1/fr unknown
-
1999
- 1999-11-02 NO NO995338A patent/NO995338L/no not_active Application Discontinuation
-
2000
- 2000-09-06 US US09/656,379 patent/US6465485B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1998050364A1 (en) | 1998-11-12 |
UY24986A1 (es) | 2001-08-27 |
AR013078A1 (es) | 2000-12-13 |
CA2288899A1 (en) | 1998-11-12 |
HUP0003608A2 (en) | 2001-03-28 |
PL336628A1 (en) | 2000-07-03 |
HUP0003608A3 (en) | 2001-06-28 |
CN1261350A (zh) | 2000-07-26 |
TR199902724T2 (xx) | 2000-04-21 |
EP0983244A1 (en) | 2000-03-08 |
BR9809591A (pt) | 2001-09-11 |
NO995338D0 (no) | 1999-11-02 |
IL132631A0 (en) | 2001-03-19 |
US6465485B1 (en) | 2002-10-15 |
AU7651898A (en) | 1998-11-27 |
JP2002501506A (ja) | 2002-01-15 |
PE68799A1 (es) | 1999-09-26 |
AU725491B2 (en) | 2000-10-12 |
MA26490A1 (fr) | 2004-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995338L (no) | Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer | |
NO985242L (no) | Tetrahydroisokinolin-derivater som modulatorer for dopamin D3-reseptorer | |
BG105467A (en) | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors | |
DK0876350T3 (da) | Pyrazolderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
TR199901665T2 (xx) | 4-(3-Heterosiklil-1-Benzoil) Pirazol ve herbisit olarak kullan�mlar� | |
ZA200400070B (en) | Ortho-substituted aryl amides for controlling invertebrate pests | |
NO179516C (no) | Arylimidazolforbindelser, anvendelse derav, og preparater inneholdende slike | |
DK0733621T3 (da) | Hidtil ukendte imidazolderivater og fremgangsmåde til fremstilling af disse | |
ATE180778T1 (de) | Aryl- und heteroaryl- pyrimidine als herbizide | |
MX9302948A (es) | Imidazolinonas fungicidas y composicion fungicida que las contiene. | |
BG96285A (bg) | 1-арил-5-/субституирани алкилиденимино/пиразоли с пестицидна активност | |
NO950082L (no) | Dioksycyklobuten-derivater som angiotensin II antangonister | |
BG102959A (en) | Benzooxazinon antagonists of domamine d4 receptor | |
MXPA04007019A (es) | Agentes de diamina para control de plagas de invertebrados. | |
AR006747A1 (es) | Compuestos herbicidas de pirazol sustituidos, composicion herbicida que los comprende y metodo de aplicacion de los mismos. | |
NO179368C (no) | Arylimidazoler med pesticidvirkning, anvendelse derav, og preparater inneholdende slike | |
AU1038000A (en) | 2,3-dihydro-1H-isoindole derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) | |
DK0464178T3 (da) | Fremgangsmåde til fremstilling af ergolinderivater | |
BG104309A (en) | 8-azabicyclo[3,2,1]octane-3-methanamine derivatives as ligands of d2 and d3 dopamine and 5ht1a and 5ht2 serotonin receptors | |
ATE219059T1 (de) | Neue pyridyl-und pyrimidylpiperazin-derivate | |
MX9605994A (es) | Formilaminofenilsulfonilureas, metodos para prepararlos y su uso como herbicidas y reguladores de crecimiento de la plantas. | |
ES2186365T3 (es) | Derivados de tetrahidroisoquinolina como moduladores de los receptores d3 de la dopamina. | |
DK1023287T3 (da) | Derivater af 3-oxo-(2H)-1,2,4-triazin som ligander for 5HT1a-receptorer | |
DK193090D0 (da) | Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf | |
SE8605458D0 (sv) | 4-hydroxycoumarin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |